Stabilised proteins for immunising against
Elimination of disulphide bond formation of cysteine-containing S. aureus antigens enhances antigen stability. The invention provides variant forms of cysteine-containing S. aureus antigen with a point mutation that replaces, deletes or modifies the cysteine residue.
1. An immunogenic composition comprising a stabilizing additive and a polypeptide comprising an amino acid sequence having at least 90% identity to the amino acid sequence of SEQ ID NO: 4, wherein the polypeptide does not contain the first eighteen amino acids of SEQ ID NO: 1, and wherein the polypeptide has no cysteine residues.
2. The composition of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, or SEQ ID NO: 7.
3. The immunogenic composition of claim 1 , wherein the stabilizing additive is selected from the group consisting of chelators of divalent metal cations, sugars, sugar alcohols, free amino acids, buffer salts, polyols, and protease inhibitors.
4. The composition of claim 1 , wherein the polypeptide is a hybrid protein.
5. The immunogenic composition of claim 1 , further comprising one or more conjugates of (i) an S.aureus exopolysaccharide and (ii) a carrier protein.
6. The immunogenic composition of claim 1 , further comprising one or more conjugates of (i) an S.aureus capsular polysaccharide and (ii) a carrier protein.
7. The immunogenic composition of claim 1 , further comprising an adjuvant, or a combination of adjuvants.
8. The immunogenic composition of claim 1 , in a lyophilized form.
9. The immunogenic composition of claim 1 , in an aqueous form.
10. A vaccine comprising the immunogenic composition of claim 1 .
11. A method for preparing an aqueous immunogenic composition, the method comprising the step of:
reconstituting the immunogenic composition of claim 8 with aqueous material, so as to form the aqueous form.